PBT 0.00% 0.0¢ prana biotechnology limited

News: PBT Prana Receives Orphan Drug Designation From FDA For Treatment Of Multiple System Atrophy

  1. 68,069 Posts.
    lightbulb Created with Sketch. 460

    Jan 31 (Reuters) - Prana Biotechnology Ltd (PBT) :

    • PRANA RECEIVES FIRST ORPHAN DRUG DESIGNATION FROM THE FDA FOR THE TREATMENT OF MULTIPLE SYSTEM ATROPHY
    • PRANA BIOTECHNOLOGY LTD - PRANA IS CONDUCTING A PHASE 1 CLINICAL TRIAL OF PBT434 AND EXPECTS IT TO BE COMPLETED THIS YEAR
 
watchlist Created with Sketch. Add PBT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.